These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 530258)

  • 41. The effect of ageing on plasma albumin and plasma protein binding of diazepam, salicylic acid and digitoxin in healthy subjects and patients with renal impairment.
    Viani A; Rizzo G; Carrai M; Pacifici GM
    Br J Clin Pharmacol; 1992 Mar; 33(3):299-304. PubMed ID: 1576051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fusidic acid binding to serum albumin and interaction with binding of bilirubin.
    Brodersen R
    Acta Paediatr Scand; 1985 Nov; 74(6):874-80. PubMed ID: 4090962
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance.
    Bertucci C; Domenici E
    Curr Med Chem; 2002 Aug; 9(15):1463-81. PubMed ID: 12173977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The classification of drugs on the basis of the drug-binding site on human serum albumin.
    Iwatsuru M; Nishigori H; Maruyama K
    Chem Pharm Bull (Tokyo); 1982 Dec; 30(12):4489-93. PubMed ID: 7168873
    [No Abstract]   [Full Text] [Related]  

  • 45. Interpretation of protein-drug interaction through fraction bound and relative contribution of secondary sites.
    Mais RF; Keresztes-Nagy S; Zaroslinski JF; Oester YT
    J Pharm Sci; 1974 Sep; 63(9):1423-7. PubMed ID: 4427265
    [No Abstract]   [Full Text] [Related]  

  • 46. Drug binding in sera deficient in lipoproteins, albumin or orosomucoid.
    Pike E; Kierulf P; Skuterud B; Bredesen JE; Lunde PK
    Br J Clin Pharmacol; 1983 Sep; 16(3):233-9. PubMed ID: 6626414
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circular dichroism and hydrodynamic measurements of ternary protein--two ligand systems: serum albumin-bilirubin-drug or alcohol.
    Lavie E; Blauer G
    Arch Biochem Biophys; 1979 Mar; 193(1):191-203. PubMed ID: 453848
    [No Abstract]   [Full Text] [Related]  

  • 48. Influence of acute renal failure on the protein binding of drugs in animals and in man.
    Belpaire FM; Bogaert MG; Mussche MM
    Eur J Clin Pharmacol; 1977; 11(1):27-32. PubMed ID: 832654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dependence of drug-protein binding parameters on human serum and albumin concentration.
    Brunner F; Zini R; Tillement JP
    J Pharm Pharmacol; 1983 Aug; 35(8):526-8. PubMed ID: 6137542
    [No Abstract]   [Full Text] [Related]  

  • 50. Drug binding properties of neonatal albumin.
    Brodersen R; Honoré B
    Acta Paediatr Scand; 1989 May; 78(3):342-6. PubMed ID: 2545072
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Warfarin-sulfinpyrazone interaction on binding to human serum albumin.
    Larsen FG; Larsen CG; Brodersen R
    J Pharm Pharmacol; 1984 Oct; 36(10):689-90. PubMed ID: 6150088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Binding of diazepam, salicylic acid and digitoxin to albumin isolated from fetal and adult serum.
    Viani A; Cappiello M; Pacifici GM
    Dev Pharmacol Ther; 1991; 17(1-2):100-8. PubMed ID: 1811915
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Binding of digitoxin to human serum albumin: influence of free fatty acids, bile acids, and protein unfolding on the digitoxin-albumin interaction.
    Brock A
    Acta Pharmacol Toxicol (Copenh); 1976 May; 38(5):497-507. PubMed ID: 989252
    [No Abstract]   [Full Text] [Related]  

  • 54. New fluorescence probes for drug-albumin interaction studies.
    Goya S; Takadate A; Fujino H; Otagiri M; Uekama K
    Chem Pharm Bull (Tokyo); 1982 Apr; 30(4):1363-9. PubMed ID: 7105256
    [No Abstract]   [Full Text] [Related]  

  • 55. An in vitro model of drug-albumin interaction [proceedings].
    McElnay JC; Arcy PF
    J Pharm Pharmacol; 1977 Dec; 29 Suppl():1P. PubMed ID: 22637
    [No Abstract]   [Full Text] [Related]  

  • 56. Binding of digitoxin to human serum albumin: influence of ionic strength and ionic medium on the digitoxin-albumin complex formation.
    Brock A
    Acta Pharmacol Toxicol (Copenh); 1975 Nov; 37(5):361-8. PubMed ID: 887
    [No Abstract]   [Full Text] [Related]  

  • 57. Intravascular factors affecting diazepam binding to human serum albumin.
    Wong GB; Sellers EM
    Biochem Pharmacol; 1979 Nov; 28(22):3265-70. PubMed ID: 393269
    [No Abstract]   [Full Text] [Related]  

  • 58. Graphical analysis of competitive binding of comparable concentrations of ligand, inhibitor and protein. Ligand binding to serum albumin.
    Kragh-Hansen U
    Biochem Pharmacol; 1983 Sep; 32(18):2679-81. PubMed ID: 6626238
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Competition between drugs and nutrients for specific ligand binding sites on human serum albumin.
    Kiem E; Fehske KJ; Müller WE
    World Rev Nutr Diet; 1984; 43():179-82. PubMed ID: 6475096
    [No Abstract]   [Full Text] [Related]  

  • 60. Drug displacement of warfarin from human serum albumin: a fluorometric analysis.
    Henry RA; Wosilait WD
    Toxicol Appl Pharmacol; 1975 Aug; 33(2):267-75. PubMed ID: 1237182
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.